xTAG | GenomeWeb

xTAG

NEW YORK (GenomeWeb) — Luminex reported after the close of the market Monday a 12 percent spike in third quarter revenues driven primarily by growth in assay sales across all major product categories.

NEW YORK (GenomeWeb) – Luminex last week provided an update on nxTAG, its next-generation multiplexing technology in development, pledging a "seamless upgrade" for existing customers of its xTAG bead array products, and promising to have nxTAG in customers' hands by sometime next year.

NEW YORK (GenomeWeb) — Luminex executives this week provided investors with an update on the progress of Aries, the sample-to-answer molecular testing platform that the company plans to launch in Europe later this year and the US next year.

NEW YORK (GenomeWeb) – Luminex said this week that double-digit growth in sales of its xTAG Respiratory Viral and Gastrointestinal Pathogen Panels contributed to an increase in first quarter revenues.

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Monday that its first quarter 2014 revenues grew 6 percent, driven by an 18 percent spike in assay sales, as well as an increase in consumables sales.

NEW YORK (GenomeWeb News) – A federal court has dismissed claims against Luminex that had alleged patent infringement.

Luminex is developing a new version of its xTAG PCR chemistry that it believes will improve the ease of use of its technology while maintaining its high-multiplex and high-throughput capabilities.

NEW YORK (GenomeWeb News) – Combinatorial chemistry systems firm Irori Technologies is suing Luminex accusing the Austin, Texas-based firm of infringing three patents with its xMAP and xTAG technologies.

This article was originally posted on Sept. 12.
Luminex has no plans to acquire any new businesses or companies at this time, its CEO Patrick Balthrop said at an investment conference last week.

Luminex is developing an automated, handheld, battery-powered diagnostic system based on its xMAP technology to administer both molecular and immunoassays to help diagnose soldiers or provide biosurveillance data at the point of need, the company said this week.

Pages

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.